Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Assets Average (2020 - 2025)

Arcutis Biotherapeutics (ARQT) has 6 years of Assets Average data on record, last reported at $348.3 million in Q2 2025.

  • For Q2 2025, Assets Average changed N/A year-over-year to $348.3 million; the TTM value through Jun 2025 reached $348.3 million, changed N/A, while the annual FY2024 figure was $345.1 million, 12.7% down from the prior year.
  • Assets Average reached $348.3 million in Q2 2025 per ARQT's latest filing, up from $346.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $479.1 million in Q4 2022 and bottomed at $306.8 million in Q3 2023.
  • Average Assets Average over 5 years is $373.9 million, with a median of $368.1 million recorded in 2022.
  • Peak YoY movement for Assets Average: surged 60.22% in 2021, then plummeted 33.8% in 2023.
  • A 5-year view of Assets Average shows it stood at $397.6 million in 2021, then increased by 20.5% to $479.1 million in 2022, then tumbled by 33.8% to $317.2 million in 2023, then grew by 23.95% to $393.1 million in 2024, then fell by 11.41% to $348.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $348.3 million in Q2 2025, $346.5 million in Q1 2025, and $393.1 million in Q4 2024.